AborayaA, ChumberP, AltahaB. The treatment-resistant catatonia patient: Ms. R develops severe catatonia after being hospitalized with agitation, delusions, and hallucinations. A benzodiazepine does not help. How would you treat her? Curr Psychiatr, 2009; 8(3):66.
2.
AdlerL, AngristB, PeselowE, et al.Efficacy of propranolol in neuroleptic-induced akathesia. J Clin Psychopharmacol, 1985; 5(3):164–166; doi: 10.1097/00004714-198506000-00009
3.
AndroutsosC.Schizophrenia in children and adolescents: Relevance and differentiation from adult schizophrenia. Psychiatriki, 2012; 23(Suppl. 1):82–93.
CohenD, FlamentM, DubosPF, et al.Case series: Catatonic syndrome in young people. J Am Acad Child Adolesc Psychiatry, 1999; 38(8):1040–1046; doi: 10.1097/00004583-199908000-00021
6.
CohenD, NicolasJD, FlamentMF, et al.Clinical relevance of chronic catatonic schizophrenia in children and adolescents: Evidence from a prospective naturalistic study. Schizophr Res, 2005; 76(2–3):301–308; doi: 10.1016/j.schres.2005.01.014
7.
CornicF, ConsoliA, TanguyML, et al.Association of adolescent catatonia with increased mortality and morbidity: Evidence from a prospective follow-up study. Schizophr Res, 2009; 113(2):233–240; doi: 10.1016/j.schres.2009.04.021
8.
GogtayN, VyasNS, TestaR, et al.Age of onset of schizophrenia: Perspectives from structural neuroimaging studies. Schizophr Bull, 2011; 37(3):504–513; doi: 10.1093/schbul/sbr030
9.
GrenierE, RyanM, KoE, et al.Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: A case report. J Nerv Ment Dis, 2011; 199(12):987–988; doi: 10.1097/NMD.0b013e3182392d7e
10.
HaasM, EerdekensM, KushnerS, et al.Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: Double-blind study. Br J Psychiatry, 2009; 194(2):158–164; doi: 10.1192/bjp.bp.107.046177
11.
HrdlickaM, DudovaI. Risperidone in adolescent schizophrenic psychoses: A retrospective study. Int J Psychiatry Clin Pract, 2007; 11(4):273–278; doi: 10.1080/13651500701246054
12.
KimCH, KimCY. Optimal dosing and long-term effects of risperidone. Clin Psychopharmacol Neurosci, 2003; 1(1):135–146.
13.
KirkbrideJB, HameedY, IoannidisK, et al.Ethnic minority status, age-at-immigration and psychosis risk in rural environments: Evidence from the SEPEA Study. Schizophr Bull, 2017; 43(6):1251–1261; doi: 10.1093/schbul/sbx010
14.
KlykyloWM, BowersR, WestonC, et al. Chapter 6: Second-generation/atypical and other antipsychotic drugs. In: Green's Child and Adolescent Clinical Psychopharmacology. Fifth. Lippincott Williams &, Wilkins: Philadelphia, PA, USA; 2014; p. 147.
15.
LeeES, KronsbergH, FindlingRL. Psychopharmacologic treatment of schizophrenia in adolescents and children. Child Adolesc Psychiatr Clin N Am, 2020; 29(1):183–210; doi: 10.1016/j.chc.2019.08.009
16.
PallaveshiL, JwelyA, SubramanianP, et al.Immigration and Psychosis: An exploratory study. J Int Migr Integr, 2017; 18(4):1149–1166; doi: 10.1007/s12134-017-0525-1
PillayJ, BoylanK, CarreyN, et al. Results. In: First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update. Comparative Effectiveness Reviews, No. 184. Agency for Healthcare Research and Quality: Rockville, MD, USA; 2017.
19.
PillayJ, BoylanK, NewtonA, et al.Harms of antipsychotics in children and young adults: A systematic review update. Can J Psychiatry, 2018; 63(10):661–678; doi: 10.1177/0706743718779950
20.
PoyurovskyM, WeizmanA. Very low-dose mirtazapine (7.5mg) in treatment of acute antipsychotic-associated Akathisia. J Clin Psychopharmacol, 2018; 38(6):609–611; doi: 10.1097/JCP.0000000000000972
21.
PringsheimT, GardnerD, AddingtonD, et al.The assessment and treatment of antipsychotic-induced Akathisia. Can J Psychiatry, 2018; 63(11):719–729; doi: 10.1177/0706743718760288
22.
QuintanaH, KeshavanM. Case Study: Risperidone in children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry, 1995; 34(10):1292–1296; doi: 10.1097/00004583-199510000-00014
23.
RaffinM, Zugaj-BensaouL, BodeauN, et al.Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry, 2015; 24(4):441–449; doi: 10.1007/s00787-014-0595-y
24.
RasmussenSA, MazurekMF, RosebushPI. Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry, 2016; 6(4):391–398; doi: 10.5498/wjp.v6.i4.391
25.
SharmaA, MadaanV, PettyF. Propranolol treatment for neuroleptic-Induced akathisia. Prim Care Companion CNS Disord, 2005; 7(4):202–203; doi: 10.4088/pcc.v07n0412b
26.
SienaertP, DhosscheDM, VancampfortD, et al.A clinical review of the treatment of catatonia. Front Psychiatry, 2014; 5:181; doi: 10.3389/fpsyt.2014.00181
27.
SmithJR, BaldwinI, YorkT, et al.Alternative psychopharmacologic treatments for pediatric catatonia: A retrospective analysis. Front Child Adolesc Psychiatry, 2023; 2:1208926; doi: 10.3389/frcha.2023.1208926
28.
TorresF.American Psychiatric Association. What Is Schizophrenia? Washington, DC, USA; 2020. Available from: https://www.psychiatry.org/patients-families/schizophrenia/what-is-schizophrenia [Last accessed: December28, 2023].
29.
ValerstainD, ZaydlinM, BezY, et al.Clonazepam treatment of adolescent catatonia in a setting of lorazepam-related hypotension. J Child Adolesc Psychopharmacol, 2023; 33(1):34–37; doi: 10.1089/cap.2022.29233.bjc
30.
VelingW, HoekHW, SeltenJP, et al.Age at migration and future risk of psychotic disorders among immigrants in the Netherlands: A 7-year incidence study. Am J Psychiatry, 2011; 168(12):1278–1285; doi: 10.1176/appi.ajp.2011.11010110
31.
ZamanH, GibsonRC, WalcottG. Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses. Cochrane Database Syst Rev, 2019; 8(8):CD006570; doi: 10.1002/14651858.CD006570.pub3
